Varian Medical Systems allies with optx
Varian Medical Systems, a major manufacturer of integrated cancer therapy systems, is partnering with optx corporation, a leading developer of medical oncology treatment management software. Under the agreement, Varian will begin globally marketing optx
Varian Medical Systems, a major manufacturer of integrated cancer therapy systems, is partnering with optx corporation, a leading developer of medical oncology treatment management software. Under the agreement, Varian will begin globally marketing optx software as a VARiS MedOncology module within its Generation 6 suite of oncology information products. The product will replace earlier versions of Varian’s VARiS MedOncology software. Installation and training for customers, as well as ongoing service and support, will be provided by optx. The optx software will help physicians craft chemotherapy regimens by providing standard and customizable treatment protocols. It will also enable physicians to record treatments and track results.
MRI Study at ARRS Raises Questions About Disparities in Detection of MASLD
May 3rd 2025New research revealed that Hispanic Americans with evidence of hepatic steatosis on MRI but no formal diagnosis of MASLD had over a fourfold higher risk of developing hepatocellular carcinoma in comparison to those who had a formal diagnosis of MASLD.
FDA Clears MRI-Based AI Segmentation of Organs at Risk During Radiation Therapy
May 2nd 2025Capable of segmenting over 37 organs and structures in the head, neck and pelvis, the MR Contour DL software is currently being showcased at the European Society for Radiotherapy and Oncology (ESTRO) conference.
